# Momenta Pharmaceuticals (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/momenta-pharmaceuticals-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 6 |
| Citations | 105,290 |
| City | Cambridge |
| Country | US |
| Description | Momenta Pharmaceuticals (United States) is a research organisation in Cambridge, US. OpenAlex records 187 works and 105,290 citations for it. 83 researchers list it as their most recent affiliation. |
| Homepage | http://www.momentapharma.com/ |
| OpenAlex ID | https://openalex.org/I4210109182 |
| Researchers | 83 |
| ROR ID | https://ror.org/01xdkk717 |
| Type | company |
| Works | 187 |

## University papers

- [Demographic characteristics and comorbidities of patients with narcolepsy: a propensity-matched cohort study](https://scholariq.org/papers/demographic-characteristics-and-comorbidities-of-patients-with-narcolepsy-a/)
- [Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System](https://scholariq.org/papers/evidence-of-accidental-dosing-errors-with-immediate-release-sodium-oxybate-data/)
- [Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial](https://scholariq.org/papers/efficacy-of-once-nightly-sodium-oxybate-ft218-in-narcolepsy-type-1-and-type-2/)
- [Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers](https://scholariq.org/papers/randomized-crossover-open-label-study-of-the-relative-bioavailability-and-safety/)
- [A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient’s Perspective](https://scholariq.org/papers/a-survey-of-people-living-with-narcolepsy-in-the-usa-path-to-diagnosis-quality/)
- [Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment](https://scholariq.org/papers/clinician-preferences-for-oxybate-treatment-for-narcolepsy-survey-and-discrete/)
- [0579 Long-Term Safety of Once-Nightly Oxybate for Narcolepsy: RESTORE Study Interim Analysis of Data](https://scholariq.org/papers/0579-long-term-safety-of-once-nightly-oxybate-for-narcolepsy-restore-study/)
- [Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial](https://scholariq.org/papers/improvement-in-sleep-latency-with-extended-release-once-nightly-sodium-oxybate/)
- [Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) Trial](https://scholariq.org/papers/weight-loss-with-once-nightly-sodium-oxybate-for-the-treatment-of-narcolepsy/)
- [Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial](https://scholariq.org/papers/efficacy-of-once-nightly-sodium-oxybate-ft218-on-daytime-symptoms-in-individuals/)
- [0732 Drug Class Utilization and Age-Related Trends in Narcolepsy and Idiopathic Hypersomnia: A Claims Database Analysis](https://scholariq.org/papers/0732-drug-class-utilization-and-age-related-trends-in-narcolepsy-and-idiopathic/)
- [RELATIVE PREVALENCE OF IDIOPATHIC HYPERSOMNIA, NARCOLEPSY TYPE 1, AND NARCOLEPSY TYPE 2: A CLAIMS DATABASE ANALYSIS](https://scholariq.org/papers/relative-prevalence-of-idiopathic-hypersomnia-narcolepsy-type-1-and-narcolepsy/)

## University researchers

- [Jennifer Gudeman](https://scholariq.org/researchers/jennifer-gudeman/)

## University top topics

Showing 8 of 25.

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Proteoglycans and glycosaminoglycans research](https://scholariq.org/topics/proteoglycans-and-glycosaminoglycans-research/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.